Search and Browse
Download
Enter Data
| Target/Host (Institution) | Ligand | Target/Host Links | Ligand Links | Trg + Lig Links | Ki nM | ΔG° kJ/mole | IC50 nM | Kd nM | EC50/IC50 nM | koff s-1 | kon M-1s-1 | pH | Temp °C |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| cAMP and cAMP-inhibited cGMP 3',5'-cyclic phosphodiesterase 10A (Homo sapiens (Human)) | BDBM119842 (US8691986, 8) | PDB MMDB Reactome pathway KEGG UniProtKB/SwissProt B.MOAD DrugBank antibodypedia GoogleScholar AffyNet  | PC cid PC sid UniChem Similars | US Patent | n/a | n/a | 0.5 | n/a | n/a | n/a | n/a | 7.2 | 25 |
Amgen Inc. US Patent | Assay Description IMAP TR-FRET progressive binding system, FAM-cAMP substrate were from Molecular Devices (Sunnyvale, Calif.). The PDE IMAP assay was conducted in a 3... | US Patent US8691986 (2014) BindingDB Entry DOI: 10.7270/Q26T0K9T | |||||||||||
| More data for this Ligand-Target Pair | |||||||||||||
| cAMP and cAMP-inhibited cGMP 3',5'-cyclic phosphodiesterase 10A (Homo sapiens (Human)) | BDBM119851 (US8691986, 15 | US9718803, 30.2) | PDB MMDB Reactome pathway KEGG UniProtKB/SwissProt B.MOAD DrugBank antibodypedia GoogleScholar AffyNet | PC cid PC sid UniChem Similars | US Patent | n/a | n/a | 1.30 | n/a | n/a | n/a | n/a | 7.2 | 25 |
Amgen Inc. US Patent | Assay Description IMAP TR-FRET progressive binding system, FAM-cAMP substrate were from Molecular Devices (Sunnyvale, Calif.). The PDE IMAP assay was conducted in a 3... | US Patent US8691986 (2014) BindingDB Entry DOI: 10.7270/Q26T0K9T | |||||||||||
| More data for this Ligand-Target Pair | |||||||||||||
| cAMP and cAMP-inhibited cGMP 3',5'-cyclic phosphodiesterase 10A (Homo sapiens (Human)) | BDBM119847 (US8691986, 13) | PDB MMDB Reactome pathway KEGG UniProtKB/SwissProt B.MOAD DrugBank antibodypedia GoogleScholar AffyNet | PC cid PC sid UniChem Similars | US Patent | n/a | n/a | 1.70 | n/a | n/a | n/a | n/a | 7.2 | 25 |
Amgen Inc. US Patent | Assay Description IMAP TR-FRET progressive binding system, FAM-cAMP substrate were from Molecular Devices (Sunnyvale, Calif.). The PDE IMAP assay was conducted in a 3... | US Patent US8691986 (2014) BindingDB Entry DOI: 10.7270/Q26T0K9T | |||||||||||
| More data for this Ligand-Target Pair | |||||||||||||
| cAMP and cAMP-inhibited cGMP 3',5'-cyclic phosphodiesterase 10A (Homo sapiens (Human)) | BDBM119850 (US8691986, 17 | US9718803, 5.19) | PDB MMDB Reactome pathway KEGG UniProtKB/SwissProt B.MOAD DrugBank antibodypedia GoogleScholar AffyNet | PC cid PC sid UniChem Similars | US Patent | n/a | n/a | 2 | n/a | n/a | n/a | n/a | 7.2 | 25 |
Amgen Inc. US Patent | Assay Description IMAP TR-FRET progressive binding system, FAM-cAMP substrate were from Molecular Devices (Sunnyvale, Calif.). The PDE IMAP assay was conducted in a 3... | US Patent US8691986 (2014) BindingDB Entry DOI: 10.7270/Q26T0K9T | |||||||||||
| More data for this Ligand-Target Pair | |||||||||||||
| cAMP and cAMP-inhibited cGMP 3',5'-cyclic phosphodiesterase 10A (Homo sapiens (Human)) | BDBM119849 (US8691986, 16 | US9718803, 30.4) | PDB MMDB Reactome pathway KEGG UniProtKB/SwissProt B.MOAD DrugBank antibodypedia GoogleScholar AffyNet | PC cid PC sid UniChem Similars | US Patent | n/a | n/a | 2.60 | n/a | n/a | n/a | n/a | 7.2 | 25 |
Amgen Inc. US Patent | Assay Description IMAP TR-FRET progressive binding system, FAM-cAMP substrate were from Molecular Devices (Sunnyvale, Calif.). The PDE IMAP assay was conducted in a 3... | US Patent US8691986 (2014) BindingDB Entry DOI: 10.7270/Q26T0K9T | |||||||||||
| More data for this Ligand-Target Pair | |||||||||||||
| cAMP and cAMP-inhibited cGMP 3',5'-cyclic phosphodiesterase 10A (Homo sapiens (Human)) | BDBM119838 (US8691986, 4) | PDB MMDB Reactome pathway KEGG UniProtKB/SwissProt B.MOAD DrugBank antibodypedia GoogleScholar AffyNet | PC cid PC sid UniChem Similars | US Patent | n/a | n/a | 2.80 | n/a | n/a | n/a | n/a | 7.2 | 25 |
Amgen Inc. US Patent | Assay Description IMAP TR-FRET progressive binding system, FAM-cAMP substrate were from Molecular Devices (Sunnyvale, Calif.). The PDE IMAP assay was conducted in a 3... | US Patent US8691986 (2014) BindingDB Entry DOI: 10.7270/Q26T0K9T | |||||||||||
| More data for this Ligand-Target Pair | |||||||||||||
| cAMP and cAMP-inhibited cGMP 3',5'-cyclic phosphodiesterase 10A (Homo sapiens (Human)) | BDBM119837 (US8691986, 3) | PDB MMDB Reactome pathway KEGG UniProtKB/SwissProt B.MOAD DrugBank antibodypedia GoogleScholar AffyNet | PC cid PC sid UniChem Similars | US Patent | n/a | n/a | 3.10 | n/a | n/a | n/a | n/a | 7.2 | 25 |
Amgen Inc. US Patent | Assay Description IMAP TR-FRET progressive binding system, FAM-cAMP substrate were from Molecular Devices (Sunnyvale, Calif.). The PDE IMAP assay was conducted in a 3... | US Patent US8691986 (2014) BindingDB Entry DOI: 10.7270/Q26T0K9T | |||||||||||
| More data for this Ligand-Target Pair | |||||||||||||
| cAMP and cAMP-inhibited cGMP 3',5'-cyclic phosphodiesterase 10A (Homo sapiens (Human)) | BDBM119848 (US8691986, 14) | PDB MMDB Reactome pathway KEGG UniProtKB/SwissProt B.MOAD DrugBank antibodypedia GoogleScholar AffyNet | PC cid PC sid UniChem Similars | US Patent | n/a | n/a | 3.60 | n/a | n/a | n/a | n/a | 7.2 | 25 |
Amgen Inc. US Patent | Assay Description IMAP TR-FRET progressive binding system, FAM-cAMP substrate were from Molecular Devices (Sunnyvale, Calif.). The PDE IMAP assay was conducted in a 3... | US Patent US8691986 (2014) BindingDB Entry DOI: 10.7270/Q26T0K9T | |||||||||||
| More data for this Ligand-Target Pair | |||||||||||||
| cAMP and cAMP-inhibited cGMP 3',5'-cyclic phosphodiesterase 10A (Homo sapiens (Human)) | BDBM119846 (US8691986, 12) | PDB MMDB Reactome pathway KEGG UniProtKB/SwissProt B.MOAD DrugBank antibodypedia GoogleScholar AffyNet | PC cid PC sid UniChem Similars | US Patent | n/a | n/a | 3.90 | n/a | n/a | n/a | n/a | 7.2 | 25 |
Amgen Inc. US Patent | Assay Description IMAP TR-FRET progressive binding system, FAM-cAMP substrate were from Molecular Devices (Sunnyvale, Calif.). The PDE IMAP assay was conducted in a 3... | US Patent US8691986 (2014) BindingDB Entry DOI: 10.7270/Q26T0K9T | |||||||||||
| More data for this Ligand-Target Pair | |||||||||||||
| cAMP and cAMP-inhibited cGMP 3',5'-cyclic phosphodiesterase 10A (Homo sapiens (Human)) | BDBM119841 (US8691986, 7) | PDB MMDB Reactome pathway KEGG UniProtKB/SwissProt B.MOAD DrugBank antibodypedia GoogleScholar AffyNet | PC cid PC sid UniChem Similars | US Patent | n/a | n/a | 4 | n/a | n/a | n/a | n/a | 7.2 | 25 |
Amgen Inc. US Patent | Assay Description IMAP TR-FRET progressive binding system, FAM-cAMP substrate were from Molecular Devices (Sunnyvale, Calif.). The PDE IMAP assay was conducted in a 3... | US Patent US8691986 (2014) BindingDB Entry DOI: 10.7270/Q26T0K9T | |||||||||||
| More data for this Ligand-Target Pair | |||||||||||||
| cAMP and cAMP-inhibited cGMP 3',5'-cyclic phosphodiesterase 10A (Homo sapiens (Human)) | BDBM119844 (US8691986, 10) | PDB MMDB Reactome pathway KEGG UniProtKB/SwissProt B.MOAD DrugBank antibodypedia GoogleScholar AffyNet | PC cid PC sid UniChem Similars | US Patent | n/a | n/a | 5.90 | n/a | n/a | n/a | n/a | 7.2 | 25 |
Amgen Inc. US Patent | Assay Description IMAP TR-FRET progressive binding system, FAM-cAMP substrate were from Molecular Devices (Sunnyvale, Calif.). The PDE IMAP assay was conducted in a 3... | US Patent US8691986 (2014) BindingDB Entry DOI: 10.7270/Q26T0K9T | |||||||||||
| More data for this Ligand-Target Pair | |||||||||||||
| cAMP and cAMP-inhibited cGMP 3',5'-cyclic phosphodiesterase 10A (Homo sapiens (Human)) | BDBM119836 (US8691986, 2) | PDB MMDB Reactome pathway KEGG UniProtKB/SwissProt B.MOAD DrugBank antibodypedia GoogleScholar AffyNet | PC cid PC sid UniChem Similars | US Patent | n/a | n/a | 6.30 | n/a | n/a | n/a | n/a | 7.2 | 25 |
Amgen Inc. US Patent | Assay Description IMAP TR-FRET progressive binding system, FAM-cAMP substrate were from Molecular Devices (Sunnyvale, Calif.). The PDE IMAP assay was conducted in a 3... | US Patent US8691986 (2014) BindingDB Entry DOI: 10.7270/Q26T0K9T | |||||||||||
| More data for this Ligand-Target Pair | |||||||||||||
| cAMP and cAMP-inhibited cGMP 3',5'-cyclic phosphodiesterase 10A (Homo sapiens (Human)) | BDBM119839 (US8691986, 5) | PDB MMDB Reactome pathway KEGG UniProtKB/SwissProt B.MOAD DrugBank antibodypedia GoogleScholar AffyNet | PC cid PC sid UniChem Similars | US Patent | n/a | n/a | 7.5 | n/a | n/a | n/a | n/a | 7.2 | 25 |
Amgen Inc. US Patent | Assay Description IMAP TR-FRET progressive binding system, FAM-cAMP substrate were from Molecular Devices (Sunnyvale, Calif.). The PDE IMAP assay was conducted in a 3... | US Patent US8691986 (2014) BindingDB Entry DOI: 10.7270/Q26T0K9T | |||||||||||
| More data for this Ligand-Target Pair | |||||||||||||
| cAMP and cAMP-inhibited cGMP 3',5'-cyclic phosphodiesterase 10A (Homo sapiens (Human)) | BDBM119840 (US8691986, 6) | PDB MMDB Reactome pathway KEGG UniProtKB/SwissProt B.MOAD DrugBank antibodypedia GoogleScholar AffyNet | PC cid PC sid UniChem Similars | US Patent | n/a | n/a | 7.60 | n/a | n/a | n/a | n/a | 7.2 | 25 |
Amgen Inc. US Patent | Assay Description IMAP TR-FRET progressive binding system, FAM-cAMP substrate were from Molecular Devices (Sunnyvale, Calif.). The PDE IMAP assay was conducted in a 3... | US Patent US8691986 (2014) BindingDB Entry DOI: 10.7270/Q26T0K9T | |||||||||||
| More data for this Ligand-Target Pair | |||||||||||||
| cAMP and cAMP-inhibited cGMP 3',5'-cyclic phosphodiesterase 10A (Homo sapiens (Human)) | BDBM119845 (US8691986, 11) | PDB MMDB Reactome pathway KEGG UniProtKB/SwissProt B.MOAD DrugBank antibodypedia GoogleScholar AffyNet | PC cid PC sid UniChem Similars | US Patent | n/a | n/a | 16.6 | n/a | n/a | n/a | n/a | 7.2 | 25 |
Amgen Inc. US Patent | Assay Description IMAP TR-FRET progressive binding system, FAM-cAMP substrate were from Molecular Devices (Sunnyvale, Calif.). The PDE IMAP assay was conducted in a 3... | US Patent US8691986 (2014) BindingDB Entry DOI: 10.7270/Q26T0K9T | |||||||||||
| More data for this Ligand-Target Pair | |||||||||||||
| cAMP and cAMP-inhibited cGMP 3',5'-cyclic phosphodiesterase 10A (Homo sapiens (Human)) | BDBM119835 (US8691986, 1) | PDB MMDB Reactome pathway KEGG UniProtKB/SwissProt B.MOAD DrugBank antibodypedia GoogleScholar AffyNet | PC cid PC sid UniChem Similars | US Patent | n/a | n/a | 28.7 | n/a | n/a | n/a | n/a | 7.2 | 25 |
Amgen Inc. US Patent | Assay Description IMAP TR-FRET progressive binding system, FAM-cAMP substrate were from Molecular Devices (Sunnyvale, Calif.). The PDE IMAP assay was conducted in a 3... | US Patent US8691986 (2014) BindingDB Entry DOI: 10.7270/Q26T0K9T | |||||||||||
| More data for this Ligand-Target Pair | |||||||||||||
| cAMP and cAMP-inhibited cGMP 3',5'-cyclic phosphodiesterase 10A (Homo sapiens (Human)) | BDBM119843 (US8691986, 9) | PDB MMDB Reactome pathway KEGG UniProtKB/SwissProt B.MOAD DrugBank antibodypedia GoogleScholar AffyNet | PC cid PC sid UniChem Similars | US Patent | n/a | n/a | 30.9 | n/a | n/a | n/a | n/a | 7.2 | 25 |
Amgen Inc. US Patent | Assay Description IMAP TR-FRET progressive binding system, FAM-cAMP substrate were from Molecular Devices (Sunnyvale, Calif.). The PDE IMAP assay was conducted in a 3... | US Patent US8691986 (2014) BindingDB Entry DOI: 10.7270/Q26T0K9T | |||||||||||
| More data for this Ligand-Target Pair | |||||||||||||
| cGMP-dependent 3',5'-cyclic phosphodiesterase (Homo sapiens (Human)) | BDBM119850 (US8691986, 17 | US9718803, 5.19) | PDB UniProtKB/SwissProt antibodypedia GoogleScholar AffyNet | PC cid PC sid UniChem Similars | US Patent | n/a | n/a | 2.16E+3 | n/a | n/a | n/a | n/a | 7.2 | 25 |
Amgen Inc. US Patent | Assay Description IMAP TR-FRET progressive binding system, FAM-cAMP substrate were from Molecular Devices (Sunnyvale, Calif.). The PDE IMAP assay was conducted in a 3... | US Patent US8691986 (2014) BindingDB Entry DOI: 10.7270/Q26T0K9T | |||||||||||
| More data for this Ligand-Target Pair | |||||||||||||
| cGMP-dependent 3',5'-cyclic phosphodiesterase (Homo sapiens (Human)) | BDBM119849 (US8691986, 16 | US9718803, 30.4) | PDB UniProtKB/SwissProt antibodypedia GoogleScholar AffyNet | PC cid PC sid UniChem Similars | US Patent | n/a | n/a | 3.30E+3 | n/a | n/a | n/a | n/a | 7.2 | 25 |
Amgen Inc. US Patent | Assay Description IMAP TR-FRET progressive binding system, FAM-cAMP substrate were from Molecular Devices (Sunnyvale, Calif.). The PDE IMAP assay was conducted in a 3... | US Patent US8691986 (2014) BindingDB Entry DOI: 10.7270/Q26T0K9T | |||||||||||
| More data for this Ligand-Target Pair | |||||||||||||
| cGMP-dependent 3',5'-cyclic phosphodiesterase (Homo sapiens (Human)) | BDBM119844 (US8691986, 10) | PDB UniProtKB/SwissProt antibodypedia GoogleScholar AffyNet | PC cid PC sid UniChem Similars | US Patent | n/a | n/a | 7.38E+3 | n/a | n/a | n/a | n/a | 7.2 | 25 |
Amgen Inc. US Patent | Assay Description IMAP TR-FRET progressive binding system, FAM-cAMP substrate were from Molecular Devices (Sunnyvale, Calif.). The PDE IMAP assay was conducted in a 3... | US Patent US8691986 (2014) BindingDB Entry DOI: 10.7270/Q26T0K9T | |||||||||||
| More data for this Ligand-Target Pair | |||||||||||||
| cGMP-dependent 3',5'-cyclic phosphodiesterase (Homo sapiens (Human)) | BDBM119842 (US8691986, 8) | PDB UniProtKB/SwissProt antibodypedia GoogleScholar AffyNet | PC cid PC sid UniChem Similars | US Patent | n/a | n/a | 1.00E+4 | n/a | n/a | n/a | n/a | 7.2 | 25 |
Amgen Inc. US Patent | Assay Description IMAP TR-FRET progressive binding system, FAM-cAMP substrate were from Molecular Devices (Sunnyvale, Calif.). The PDE IMAP assay was conducted in a 3... | US Patent US8691986 (2014) BindingDB Entry DOI: 10.7270/Q26T0K9T | |||||||||||
| More data for this Ligand-Target Pair | |||||||||||||
| cGMP-dependent 3',5'-cyclic phosphodiesterase (Homo sapiens (Human)) | BDBM119847 (US8691986, 13) | PDB UniProtKB/SwissProt antibodypedia GoogleScholar AffyNet | PC cid PC sid UniChem Similars | US Patent | n/a | n/a | 1.00E+4 | n/a | n/a | n/a | n/a | 7.2 | 25 |
Amgen Inc. US Patent | Assay Description IMAP TR-FRET progressive binding system, FAM-cAMP substrate were from Molecular Devices (Sunnyvale, Calif.). The PDE IMAP assay was conducted in a 3... | US Patent US8691986 (2014) BindingDB Entry DOI: 10.7270/Q26T0K9T | |||||||||||
| More data for this Ligand-Target Pair | |||||||||||||
| cGMP-dependent 3',5'-cyclic phosphodiesterase (Homo sapiens (Human)) | BDBM119843 (US8691986, 9) | PDB UniProtKB/SwissProt antibodypedia GoogleScholar AffyNet | PC cid PC sid UniChem Similars | US Patent | n/a | n/a | 1.00E+4 | n/a | n/a | n/a | n/a | 7.2 | 25 |
Amgen Inc. US Patent | Assay Description IMAP TR-FRET progressive binding system, FAM-cAMP substrate were from Molecular Devices (Sunnyvale, Calif.). The PDE IMAP assay was conducted in a 3... | US Patent US8691986 (2014) BindingDB Entry DOI: 10.7270/Q26T0K9T | |||||||||||
| More data for this Ligand-Target Pair | |||||||||||||
| cGMP-dependent 3',5'-cyclic phosphodiesterase (Homo sapiens (Human)) | BDBM119846 (US8691986, 12) | PDB UniProtKB/SwissProt antibodypedia GoogleScholar AffyNet | PC cid PC sid UniChem Similars | US Patent | n/a | n/a | 1.00E+4 | n/a | n/a | n/a | n/a | 7.2 | 25 |
Amgen Inc. US Patent | Assay Description IMAP TR-FRET progressive binding system, FAM-cAMP substrate were from Molecular Devices (Sunnyvale, Calif.). The PDE IMAP assay was conducted in a 3... | US Patent US8691986 (2014) BindingDB Entry DOI: 10.7270/Q26T0K9T | |||||||||||
| More data for this Ligand-Target Pair | |||||||||||||
| cGMP-dependent 3',5'-cyclic phosphodiesterase (Homo sapiens (Human)) | BDBM119837 (US8691986, 3) | PDB UniProtKB/SwissProt antibodypedia GoogleScholar AffyNet | PC cid PC sid UniChem Similars | US Patent | n/a | n/a | 1.00E+4 | n/a | n/a | n/a | n/a | 7.2 | 25 |
Amgen Inc. US Patent | Assay Description IMAP TR-FRET progressive binding system, FAM-cAMP substrate were from Molecular Devices (Sunnyvale, Calif.). The PDE IMAP assay was conducted in a 3... | US Patent US8691986 (2014) BindingDB Entry DOI: 10.7270/Q26T0K9T | |||||||||||
| More data for this Ligand-Target Pair | |||||||||||||
| cGMP-dependent 3',5'-cyclic phosphodiesterase (Homo sapiens (Human)) | BDBM119848 (US8691986, 14) | PDB UniProtKB/SwissProt antibodypedia GoogleScholar AffyNet | PC cid PC sid UniChem Similars | US Patent | n/a | n/a | 1.00E+4 | n/a | n/a | n/a | n/a | 7.2 | 25 |
Amgen Inc. US Patent | Assay Description IMAP TR-FRET progressive binding system, FAM-cAMP substrate were from Molecular Devices (Sunnyvale, Calif.). The PDE IMAP assay was conducted in a 3... | US Patent US8691986 (2014) BindingDB Entry DOI: 10.7270/Q26T0K9T | |||||||||||
| More data for this Ligand-Target Pair | |||||||||||||
| cGMP-dependent 3',5'-cyclic phosphodiesterase (Homo sapiens (Human)) | BDBM119845 (US8691986, 11) | PDB UniProtKB/SwissProt antibodypedia GoogleScholar AffyNet | PC cid PC sid UniChem Similars | US Patent | n/a | n/a | 1.00E+4 | n/a | n/a | n/a | n/a | 7.2 | 25 |
Amgen Inc. US Patent | Assay Description IMAP TR-FRET progressive binding system, FAM-cAMP substrate were from Molecular Devices (Sunnyvale, Calif.). The PDE IMAP assay was conducted in a 3... | US Patent US8691986 (2014) BindingDB Entry DOI: 10.7270/Q26T0K9T | |||||||||||
| More data for this Ligand-Target Pair | |||||||||||||
| cGMP-dependent 3',5'-cyclic phosphodiesterase (Homo sapiens (Human)) | BDBM119841 (US8691986, 7) | PDB UniProtKB/SwissProt antibodypedia GoogleScholar AffyNet | PC cid PC sid UniChem Similars | US Patent | n/a | n/a | 1.00E+4 | n/a | n/a | n/a | n/a | 7.2 | 25 |
Amgen Inc. US Patent | Assay Description IMAP TR-FRET progressive binding system, FAM-cAMP substrate were from Molecular Devices (Sunnyvale, Calif.). The PDE IMAP assay was conducted in a 3... | US Patent US8691986 (2014) BindingDB Entry DOI: 10.7270/Q26T0K9T | |||||||||||
| More data for this Ligand-Target Pair | |||||||||||||
| cGMP-dependent 3',5'-cyclic phosphodiesterase (Homo sapiens (Human)) | BDBM119840 (US8691986, 6) | PDB UniProtKB/SwissProt antibodypedia GoogleScholar AffyNet | PC cid PC sid UniChem Similars | US Patent | n/a | n/a | 1.00E+4 | n/a | n/a | n/a | n/a | 7.2 | 25 |
Amgen Inc. US Patent | Assay Description IMAP TR-FRET progressive binding system, FAM-cAMP substrate were from Molecular Devices (Sunnyvale, Calif.). The PDE IMAP assay was conducted in a 3... | US Patent US8691986 (2014) BindingDB Entry DOI: 10.7270/Q26T0K9T | |||||||||||
| More data for this Ligand-Target Pair | |||||||||||||
| cGMP-dependent 3',5'-cyclic phosphodiesterase (Homo sapiens (Human)) | BDBM119839 (US8691986, 5) | PDB UniProtKB/SwissProt antibodypedia GoogleScholar AffyNet | PC cid PC sid UniChem Similars | US Patent | n/a | n/a | 1.00E+4 | n/a | n/a | n/a | n/a | 7.2 | 25 |
Amgen Inc. US Patent | Assay Description IMAP TR-FRET progressive binding system, FAM-cAMP substrate were from Molecular Devices (Sunnyvale, Calif.). The PDE IMAP assay was conducted in a 3... | US Patent US8691986 (2014) BindingDB Entry DOI: 10.7270/Q26T0K9T | |||||||||||
| More data for this Ligand-Target Pair | |||||||||||||
| cGMP-dependent 3',5'-cyclic phosphodiesterase (Homo sapiens (Human)) | BDBM119838 (US8691986, 4) | PDB UniProtKB/SwissProt antibodypedia GoogleScholar AffyNet | PC cid PC sid UniChem Similars | US Patent | n/a | n/a | 1.00E+4 | n/a | n/a | n/a | n/a | 7.2 | 25 |
Amgen Inc. US Patent | Assay Description IMAP TR-FRET progressive binding system, FAM-cAMP substrate were from Molecular Devices (Sunnyvale, Calif.). The PDE IMAP assay was conducted in a 3... | US Patent US8691986 (2014) BindingDB Entry DOI: 10.7270/Q26T0K9T | |||||||||||
| More data for this Ligand-Target Pair | |||||||||||||
| cGMP-dependent 3',5'-cyclic phosphodiesterase (Homo sapiens (Human)) | BDBM119836 (US8691986, 2) | PDB UniProtKB/SwissProt antibodypedia GoogleScholar AffyNet | PC cid PC sid UniChem Similars | US Patent | n/a | n/a | 1.00E+4 | n/a | n/a | n/a | n/a | 7.2 | 25 |
Amgen Inc. US Patent | Assay Description IMAP TR-FRET progressive binding system, FAM-cAMP substrate were from Molecular Devices (Sunnyvale, Calif.). The PDE IMAP assay was conducted in a 3... | US Patent US8691986 (2014) BindingDB Entry DOI: 10.7270/Q26T0K9T | |||||||||||
| More data for this Ligand-Target Pair | |||||||||||||
| cGMP-dependent 3',5'-cyclic phosphodiesterase (Homo sapiens (Human)) | BDBM119835 (US8691986, 1) | PDB UniProtKB/SwissProt antibodypedia GoogleScholar AffyNet | PC cid PC sid UniChem Similars | US Patent | n/a | n/a | 1.00E+4 | n/a | n/a | n/a | n/a | 7.2 | 25 |
Amgen Inc. US Patent | Assay Description IMAP TR-FRET progressive binding system, FAM-cAMP substrate were from Molecular Devices (Sunnyvale, Calif.). The PDE IMAP assay was conducted in a 3... | US Patent US8691986 (2014) BindingDB Entry DOI: 10.7270/Q26T0K9T | |||||||||||
| More data for this Ligand-Target Pair | |||||||||||||
| cGMP-dependent 3',5'-cyclic phosphodiesterase (Homo sapiens (Human)) | BDBM119851 (US8691986, 15 | US9718803, 30.2) | PDB UniProtKB/SwissProt antibodypedia GoogleScholar AffyNet | PC cid PC sid UniChem Similars | US Patent | n/a | n/a | 1.00E+4 | n/a | n/a | n/a | n/a | 7.2 | 25 |
Amgen Inc. US Patent | Assay Description IMAP TR-FRET progressive binding system, FAM-cAMP substrate were from Molecular Devices (Sunnyvale, Calif.). The PDE IMAP assay was conducted in a 3... | US Patent US8691986 (2014) BindingDB Entry DOI: 10.7270/Q26T0K9T | |||||||||||
| More data for this Ligand-Target Pair | |||||||||||||
